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Background: Despite high success rate of DREZ lesioning in the treatment of intractable central pain, there is still a
significant incidence of patients without satisfactory post-operative effect. The aim of the study was to evaluate the
long-term effect of DREZ lesioning using both a subjective assessment using a visual analog scale (VAS) to quantify
residual pain and an assessment using the screening tool (painDETECT Questionnaire, PD-Q).
Methods: DREZ lesioning was performed in 52 patients from a total 441 cases with brachial plexus injury (11.8%)
during a 17-year period (1995–2011). The effect of surgery was retrospectively assessed in 48 patients.
Results: A decrease in pre-operative pain by more than 75% (Group I) was achieved in 70.8% of patients and
another 20.8% reported significant improvement (Group II). The surgery was unsucessful in 8.4% (Group III). We
found a significant correlation between ‘improvement’ groups from both methods of assessments. Patients from
Group I usually complained of residual nociceptive pain according to PD-Q, patients from Group II typically had pain
of unclear origin, and all cases those in Group III suffered from neuropathic pain, Cramer’s V = .66, P < .001. Overall,
66.7% of patients had resolved neuropathic pain, 20.8% patients had more serious complaints and may also suffer
from residual neuropathic pain, while 12.5% had unresolved neuropathic pain.
Conclusion: DREZ lesioning is a safe and effective method with success rates of about 90%. PD-Q scores
correspond to subjective satisfaction with the surgery and it seems to be a suitable screening tool for finding
patients with residual neuropathic pain after surgery.
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Pain is an early symptom in up to 70% of patients with
brachial plexus injury. In up to 20% of cases severe in-
tractable pain develops. Persistent pain with sporadic
acral irritations described by patients as cutting or burn-
ing, is typical [1,2]. In 90%, the pain corresponds to the
avulsion of one of the lower roots. Pain does not appear
at the time of injury, but typically several days after.
Pathophysiology of the pain is not fully clarified, but it
originates after the loss of sensory impulses from the* Correspondence: rkaiser@hotmail.cz
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reproduction in any medium, provided the orperiphery which leads to the creation of pathologic pain
generator in the dorsal horn of the spinal cord, in
Rexed’s lamina I [3]. Irritations are treatable with stand-
ard analgesics in the early stages and often surcease with
the restoration of sensory innervation of the median
nerve. Although central neuropathic pain is often refrac-
tory, pharmacotherapy may give satisfactory or even
good relief. Worth trying are the gabapentinoids, tricyclic
antidepressants, tramadol, and for partial injuries, lamotri-
gine [4,5]. However, if pain treatment is inadequate and
pain progresses it indicates that a central component is
present. The only causal therapy is in these situations is
DREZ (dorsal root entry zone) thermocoagulation (DREZ-
T) [2,3,6-10], which was first described by Nashold [8].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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herpetic neuralgia or in pain after spinal cord trauma, but
results are generally not as favorable [11].
To our knowledge, no study has evaluated residual
neuropathic pain or success of DREZ-T using a screen-
ing tool. The painDETECT Questionnaire (PD-Q) was
developed in Germany for use in individuals with back
pain and incorporates an easy to use patient-based (self-
report) questionnaire that does not require a clinical
examination [12].
The aim of this study was to evaluate the long-term ef-
fect of DREZ-T in patients treated for severe neuro-
pathic pain that developed after brachial plexus injury.
The evaluation used both a subjective assessment using
a visual analog scale (VAS) to quantify residual pain and
an assessment using the PD-Q score [12]. Additionally,
we wanted to test the usefulness of the screening tools
in evaluating residual neuropathic pain in such patients.
Methods
A total of 52 DREZ thermocoagulations have been per-
formed, by the senior author, during the period 1995 –
2011 (P. H., Dept. of Neurosurgery, General Military
Hospital, Prague, since 1998 present department). Surgi-
cal procedures were completed on 48 men and four
women with an average age of 40 years (SD = 9.6, range
21 – 70). Twenty-nine cases were localized on the right
and 23 on the left side. Patient data are summarized in
Table 1.
The study was approved by the hospital institutional
review board and informed consent to participate in the
study and for the publication of individual clinical details
was obtained from each patient.
Indication criteria
Patients were indicated for DREZ-T after development
of severe, unbearable pain in the affected extremity after
all types of analgesia (including high dose of opioids, an-
ticonvulsants and tricyclic antidepressants) had been
tried and found to be inadequate. The vast majority of
procedures were performed before a planned reconstruc-
tion of the brachial plexus. All patients underwent pre-
operative EMG examination using needle concentric
electrodes and nerve conduction studies. CT myelogra-
phy showed avulsion of minimally two cervical roots in
all patients.
Operative technique
The procedures were performed in the semi-sitting pos-
ition with the head fixed in three-point fixation after shav-
ing the occipital area. An incision was made vertically
from external occipital protuberance to the vertebra pro-
minens. Multilevel hemilaminectomies (2–4) were per-
formed to expose the spinal cord at the level of the nerveroot avulsion. Laminectomy and durotomy were extended
until finding the nearest outgoing posterior root. The le-
sions were made after DREZ localization (see below),
using a radiofrequency electrode with a tip depth 2 mm
under the spinal cord surface. Lesioning time was 15 s,
lesioning temperature was 75°C; lesioning device was a
Radionics RFG-3C Plus (Valleylab, Colorado, USA).
The strip electrode with two active members (each
1 mm in diameter, 5 mm distance between them) was
slipped under the dura at the rostral end of exposed
spinal cord. Responses were amplified at a gain setting
of 100 with the high frequency filter set at 5 kHz and
the low frequency filter set at 20 Hz. Responses were not
averaged (Dantec Counterpoint 2, Minneapolis, USA).
The stimulating electrode was a bipolar stimulating elec-
trode with constant distance between tips of 1 mm. A
200-μsec square-wave impulse and a stimulation rate of
3 stimuli per second were used.
Initially the stimulating electrode was placed over the
dorsal column. The distance between stimulating and re-
cording electrodes varied from 3 to 8 cm. The intensity
of the stimulus was gradually increased until an evoked
potential with amplitude of approximately 30 – 50 uV
was elicited. The stimulus intensity was not changed
during the rest of procedure and ranged from 0.1 to
0.9 mA. Using an operating microscope, the neurosurgeon
gradually stimulated dorsolateral surface of spinal cord at
a constant distance from the registration electrode, in ap-
proximately 2 mm steps. Sites where the stimulation elec-
trode failed to evoke a response were considered DREZ
and a thermocoagulation lesion was made at that site. The
stimulating technique was repeated along the long axis of
the spinal cord at 1 cm intervals. Our operative technique
was previously published [10].
Postoperative examination
All patients were hospitalized for one week. Patients
were examined clinically every half year. Minimum time
of follow-up was two years. The last evaluation was a
clinical examination at our outpatient clinic in the more
recent cases or via mail in patients who underwent sur-
gery more than five years ago. At first, the residual pain
was assessed using VAS with the present-day score
counted as a percentage decrease from the original level.
Based on these scores, patients were divided into three
groups according to intensity of residual pain (Table 2).
Next the patients were assessed using the official Czech
version of the painDETECT Questionnaire (PD-Q) [12].
This screening tool was chosen for its simplicity and be-
cause it does not require a clinical examination.
Statistical analysis
The results were analyzed using ANOVA with post-hoc
analysis using the Fisher LSD test (for continuous data)










1 27, m 24 - 2 6 170
2 45, f 25 - 1 14 156
3 28, m 32 - 1 6 140
4 45, m 19 - - - D
5 51, m 25 - 1 12 110
6 25, m 28 - 2 15 169
7 23, m 39 Motor 2 6 167
8 47, m 22 - - - N/A
9 50, m 15 - 3 33 155
10 47, m 29 - 1 6 178
11 31, m 45 - 2 15 150
12 35, m 25 - 1 4 139
13 22, m 25 - 1 10 180
14 70, m 31 - 1 6 120
15 45, f 21 - 2 18 113
16 27, m 33 Motor 2 7 115
17 25, m 29 - 1 8 159
18 38, m 42 Sensory 1 12 126
19 40, m 25 - 1 9 108
20 48, m 40 - 1 5 105
21 40, m 32 - 1 5 100
22 39, m 29 - - - D
23 50, m 20 - - - N/A
24 29, m 47 Sensory, Motor 1 5 82
25 40, m 38 - 1 9 76
26 58, m 41 - 1 8 70
27 35, m 16 - 2 15 68
28 55, m 34 - 1 7 67
29 38, m 48 - 1 0 67
30 31, m 50 - 3 30 63
31 35, m 25 - 1 5 62
32 51, m 26 - 1 12 61
33 24, m 45 - 2 21 60
34 47, m 22 Sensory 1 9 59
35 40, m 18 - 1 10 58
36 57, m 29 - 1 5 57
37 49, m 20 - 3 24 51
38 29, m 37 - 1 16 50
39 28, m 26 - 1 13 49
40 51, m 44 - 1 17 48
41 32, m 25 Sensory 1 8 47
42 45, m 16 - 2 16 46
43 28, m 40 - 1 2 45
Table 1 Group of patients undergoing DREZ
thermocoagulation (Continued)
44 42, f 37 - 1 5 44
45 33, m 29 Sensory 1 6 37
46 33, m 39 - 3 29 36
47 41, m 49 Sensory 2 25 33
48 21, m 39 - 1 4 32
49 29, m 28 - 1 4 31
50 55, m 25 - 1 14 28
51 34, m 33 - 1 5 26
52 20, f 34 - 1 6 26
M, f – male, female. Effect – intensity of preoperative pain, 1 = Group I, 2 =
Group II, 3 = Group III – see Table 2. PD-Q score – assessed by painDETECT
Questionnaire. D – patient deceased, N/A – patient not available for
follow-up examination.
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data). Analyses were done using Statistica 10.0 software
(StatSoft Inc., Tulsa, Oklahoma, USA) and R (http://www.
r-project.org). Significance was assumed at p <0.05.
Results
Thermal lesions were performed over the entire range
of avulsions in all patients, the average number of le-
sions was 31 (SD = 7.9, range 15 – 50). Fifty-one pa-
tients had procedures before or just after reconstruction
of the brachial plexus; one man was successfully treated
28 years after the original accident. Of the 441 patients
undergoing a brachial plexus reconstruction, the ther-
mal lesion group represented 11.8%. Of 52 patients
treated with thermal lesions, we were able to obtain data
regarding the subjective assessment of their condition in
48 cases. Two men died of unrelated causes and another
two patients could not be contacted for the final follow-up
examination.
A decrease in pre-operative pain intensity of more
than 75% was considered a definite success. Based on
our follow-up, this goal was achieved in 70.8% of pa-
tients. Another 20.8% reported significant improvement,
but with some pain persistence, usually in the form of
dull pain or paresthesias of the affected upper limb.
Overall satisfaction with the surgery was achieved in
91.6% of patients. The surgery was considered to be un-
successful in the remaining four cases (8.4%). In two
cases, after improvement in the early post-operative
period, progressive worsening to the original level began
at one and three months post-surgery. The two other
cases reported persistence of very severe dull pain. In one
case the patient decided to amputate the affected limb;
however, this also failed to resolve the issue (No. 30).
The PD-Q score was in agreement with subjective as-
sessments of residual pain: the average pain score in
Group I (7.85) was statistically significantly lower than
Table 2 Details of post-surgery residual pain
Decrease of preoperative pain Number of patients (%) Average PD-Q score Screening results No : Un : Ne (%)
Group I > 75% 34 (70.8%) 7.85 (SD = 3.25, range 0–17)0* 29 (85.3% #) : 5 (14.7%) : 0
Group II 75 - 50% 10 (20.8%) 14.4 (SD = 4.8, range 6–25)* 3 (30%) : 5 (50% #): 2 (20%)
Group III < 50% 4 (8.4%) 29 (SD = 2.5, range 24–33)* 0 : 0 : 4 (100% #)
Decrease of preoperative pain – percentage decrease of preoperative VAS, PD-Q score - painDETECT Questionnaire score, Screening results: No – Nociceptive - a
total score of ≤12, a neuropathic pain component is unlikely, Un – result is unclear, a neuropathic pain component could be present, Ne – Neuropathic, a score
of ≥19, a neuropathic component is likely, Number of cases and (%) – percentage of cases within main group. * - statistically significant difference between all
three groups (P < .001, ANOVA with post-hoc analysis using the Fisher LSD test), # - statistically significant correlation between adequate groups (Group I –
No, Group II – Un, Group III – Ne) (Cramer’s V = .66, Yates’Chi-square P < .001).
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than in Group III (29, p <0.001). We found a statistically
significant correlation between adequate-treatment
groups (Group I – Nociceptive pain, Group II – Un-
clear, Group III – Neuropathic pain) (Cramer’s V 0.66,
p <0.001). It was observed that 32/48 (66.7%) patients
lost neuropathic pain, 10/48 (20.8%) patients had more
serious complaints and may ultimately suffer from re-
sidual neuropathic pain while 6/48 (12.5%) had neuro-
pathic pain. Details are summarized in Table 2 and the
values are shown in Figure 1.
Post-operative complications occurred in 8 (15.4%) pa-
tients. In five cases, sensory deficits (4× hypoesthesia of
ipsilateral lower extremity, 1× hemihypoesthesia of the
trunk and lower limb) occurred. Motor leg weakness oc-
curred in two patients and one case had a combined dis-
ability. Excluding the patient with hemihypoesthesia, in
which there was a partial restoration of body sensitivity,
all other patient complaints resolved and returned to
pre-operative conditions.
Discussion
The success and safety of DREZ-T in the treatment of
intractable central pain caused by cervical root(s) avul-
sion have been confirmed repeatedly [2,6-10,13-15].
Generally, an immediate loss of pain can be achieved in
60 to 80% of cases, but the percentage decreases asFigure 1 PainDETECT Questionnaire score (PD-Q score) in all three grtime-after-accident increases. Some studies have found
that the pain returns to some degree after several years
in up to one-fifth of patients [2,13,14]; however, this was
not confirmed by our study. Severe pain returned after
several months only in two cases from Group III, none
of the other patients reported any significant worsening
or change of the quantity of residual pain over time.
Some patients reported a change of quality of pain or ir-
ritations, but the change did not have a significant im-
pact on their opinion regarding the effectiveness of the
surgery.
An operative painkilling surgery is generally required
in 10 to 15% of patients with spinal cord root avulsion
[16,17]. Chen et al., for example, found that in a group
of more than 500 patients, 60 DREZ thermocoagulations
were performed (~12%) [13]. Our set of 11.8% corre-
sponds to foreign experiences [13,18].
We divided patients into three groups (Table 2) ac-
cording to Aichaoui et al.: Group I corresponds to VAS
reduction up to 75%, these patients do not require sup-
plemental analgesics, Group II – VAS reduction was be-
tween 50 and 75%, patients sometimes take analgesics
and retrospectively would still agree to have the surgery,
and Group III, which corresponds to VAS decrease less
than 50%, such patients usually take painkillers (WHO
Class II or opioids) and retrospectively would not undergo
the surgery again.oups. For details see Table 2.
Haninec et al. BMC Neurology 2014, 14:225 Page 5 of 6
http://www.biomedcentral.com/1471-2377/14/225It has been stated that there is no correlation between
the number of roots avulsed or the extent of the DREZ-
T procedure performed and the degree of pain reduction
[17]. The best results have been achieved in sporadic ir-
ritations while persistent dull pain had a worse prognosis
and higher tendency to recur [1,19]. This is in accord-
ance with our study - all 10 patients from Group II had
residual dull pain and only two from Group III had the
same pain as before the surgery, while another two were
relieved of only the strongest paroxysmal irritations. The
results show that paroxysmal pain was successfully elim-
inated in 91.6% while severe dull pain was treatable in
70.8% cases. Patients from Group I usually reported only
paroxysmal paresthesias or mild paroxysmal dull pain;
some of them realized, for the first time during testing,
that they still had some sensory disturbances. Our re-
sults are also parallel those presented in the broader lit-
erature [1,2,13,14].
The PD-Q was validated in a group of 392 individuals
with nociceptive and neuropathic pain. Of its nine items,
seven relate to sensory responses and two relate to tem-
poral and spatial characteristics of the pain pattern. A
total score ≤12 indicates that a neuropathic pain compo-
nent is unlikely, whereas a score of ≥19 indicates that a
neuropathic component is likely. Between these values
the result are uncertain and a neuropathic pain compo-
nent could be present. It has more than 80% sensitivity,
specificity and positive predictive accuracy in the diag-
nosis of a neuropathic component in patients with low
back pain [12]. This scale was used for evaluation of
neuropathic pain in patients with spinal cord injuries
with 68% sensitivity, 83% specificity and 78% diagnostic
accuracy [20]. It can be also used for other types of
neuropathic pain [21]. We used this screening tool be-
cause many of our patients live far from our department
and were not inclined to travel to our facility for a clin-
ical assessment so many years after surgery.
If we compare the success rate using a VAS decrease
and the PD-Q scale, the results are similar (p <0.001):
70.8% (Group I): 66.7% (nociceptive pain), 20.8%
(Group II): 20.8% (unclear pain) and 8.4% (Group III):
12.5% (neuropathic pain). The small differences prob-
ably result from (1) individual subjective assessment of
pain intensity or (2) even if pre-operative pain intensity
decreased dramatically, it is still possible that the pa-
tient has residual neuropathic pain. Our results suggest
two clear conclusions about residual pain in our patients:
(1) patients who are very satisfied with the effect of surgery
(Group I) most often suffered from (obvious) nociceptive
pain (85.3%) and (2) patients, in whom the surgery failed,
had suffered from (obvious) neuropathic pain (100%,
p <0.001). Patients in Group II, who were partially satisfied
with the effectiveness of the surgery, might very well, suf-
fer from a combination of nociceptive and neuropathicpain. The presence of nociceptive pain after brachial plexus
injury seems to be unexpected. However, it may originate
in the areas of preserved nerve supply in incomplete injur-
ies or develop later in the areas reinnervated by neurotiza-
tion. We can therefore conclude that it would be useful to
evaluate patients who were not fully satisfied with the ef-
fectiveness of the DREZ-T surgery, using a screening tool
like the PD-Q, which could reveal a potential neuropathic
component of their residual pain. In such cases, a more ef-
fective conservative treatment would be indicated.
The risk of this procedure includes potentially serious
neurological complications. The close proximity of corti-
cospinal tract laterally and dorsal column medial lemniscal
tract dorso-medially creates a risk motor failure of the ip-
silateral lower extremity or sensitivity failure from the
point of damage with lower limb ataxia, respectively. Ana-
tomical and functional localization of DREZ is therefore
essential for overall success. With careful monitoring,
finding of vertical zero line is not usually difficult even
though it is known that the distance from the midline to
the DREZ can be quite variable [22]. Problems tend to
occur in cases involving multiple avulsions with the pres-
ence of pseudomeningocele and dural scarring. They can
cause changes in spinal anatomical arrangement of the
surface. Needless to say, such delicate procedures require
masterful execution; additionally, the radiofrequency elec-
trode must be inserted to maximum depth of 2 mm and
must be completely perpendicularly to the surface of the
spinal cord and must be used in compliance with pre-
scribed parameters (75°C, 15 seconds) [6,7,10]. The inci-
dence of complications is different for different authors,
ranging from 0 to 60% [18]. In our group, the frequency of
complications was 15.4%.
Recent information has clouded the issue of deafferen-
tation pain and made it a little less simple than previously
thought. Deafferentation pain probably does not occur in
children (both older with traumatic injuries, and infants
with perinatal injuries) [23]. Aly et al. reported that elec-
trical motor cortex stimulation is more effective for con-
tinuous than paroxysmal pain after brachial plexus injury
[24]. The complete disappearance of pain after successful
reinnervation [22] or only after endoneurolysis or neuroma
removal [25] has been described. According to Bertelli
et al., not all pain should be considered as deafferentation
pain. They observed that in 400 patients, following rhizot-
omy performed for spasticity, deafferentation pain did not
develop [3]. Other work from Bertelli suggests that the pain
is not caused (or at least not always) by the avulsion, but is
generated by the root(s), which remained intact. In 80% of
patients with at least one well-preserved root, the pain sub-
sided within three weeks after grafting. Another group, pain
from an old injury was eliminated after selective anesthesia
of preserved root using a CT-navigated technique [26]. The
most recent study published by this author shows that pain
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(84%) and, more interestingly, in cases where the avulsion
of C8-Th1 was the only injury, deafferentation pain was
never present [27]. Bonilla et al. described similar results
with the subsidence of irritations after plexus element
neurolysis or reconstruction, with pain subsiding in 78%
of cases [6]. These studies are, however, not confirmed by
published DREZ-T results [8,14] or by the case report of a
man who was still pain free 26 years after the procedure
[28] or by our current results. We think DREZ thermocoa-
gulation is still a very effective method for treatment of se-
vere neuropathic pain that can develops in some patients
with supra-ganglion brachial plexus injury.
Conclusion
We conclude that approximately 90% of our patients
were satisfied with the effectiveness of DREZ thermo-
coagulation for intractable deafferentation pain after a
brachial plexus injury.
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